Skip to main content
SpringerLink
Log in

Frontiers in Cardiovascular Health

  • Book
  • © 2003

Overview

Editors:
  1. Naranjan S. Dhalla

    1. Institute of Cardiovascular Sciences St. Boniface General Hospital Research Centre Faculty of Medicine, University of Manitoba, Winnipeg, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Arun Chockalingam

    1. Institute of Circulatory & Respiratory Health, Canadian Institutes of Health Research, Vancouver, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. H. Ivan Berkowitz

    1. Institute of Cardiovascular Sciences St. Boniface General Hospital Research Centre Faculty of Medicine, University of Manitoba, Winnipeg, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Pawan K. Singal

    1. Institute of Cardiovascular Sciences St. Boniface General Hospital Research Centre Faculty of Medicine, University of Manitoba, Winnipeg, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Progress in Experimental Cardiology (PREC, volume 9)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (41 chapters)

  1. Front Matter

    Pages i-xvii
    Download chapter PDF

  2. Risk Factors and Cardiovascular Disease

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Inflammation and Cardiovascular Disease

      • James T. Willerson
      Pages 3-18

    3. The Role of Inflammation in Cardiac Function and Repair

      • Mark L. Entman, Keith A. Youker, Venkatesh Lakshminarayanan, Tareck O. Nossuli, Oliver Dewald, C. Wayne Smith et al.
      Pages 19-28

    4. Cardiac Repair Following Infarction

      • Yao Sun, Karl T. Weber
      Pages 29-35

    5. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease

      • Václav Pelouch, Marie Milerová, Bohumil Hučín, Michaela Adamcová, Blanka Panušková, Jan Škovránek
      Pages 37-53

    6. Human Atherosclerosis: New Participants?

      • Yu. A. Romanov, E. L. Soboleva, V. N. Smirnov, A. Bobik
      Pages 55-72

    7. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart

      • Salvatore Pepe
      Pages 73-82

    8. The Role of Nuclear Receptors in HDL Formation

      • Gordon A. Francis
      Pages 83-95

    9. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates

      • Punam K. Chohan, Thomas Netticadan, Naranjan S. Dhalla
      Pages 97-107

    10. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients

      • Chiara Bolego, Andrea Poli, Rodolfo Paoletti
      Pages 109-117

    11. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase

      • Thomas Chacko Pulinilkunnil, Nandakumar Sambandam, Brian Rodrigues
      Pages 119-143

    12. Does Reperfusion Cause Any Injury to the Myocardium?

      • Petr Ostadal, Irena Zdobnicka, Naranjan S. Dhalla
      Pages 145-157

    13. Fulminant Myocarditis—From Lethal Disease to Survival

      • Tohru Izumi, Naoyoshi Aoyama, Mototsugu Nishii, Hitoshi Takehana, Chieko Matsuda, Ken Kohno et al.
      Pages 159-169

    14. Homocysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study

      • Ramesh N. Kundur, Maureen P. Flattery, Michael L. Hess
      Pages 171-176

    15. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT 1 vs. PPARalpha Effects of Etomoxir

      • Heinz Rupp, Angel Zarain-Herzberg, Bernhard Maisch
      Pages 177-194

    16. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations

      • Akinori Kimura, Manatsu Ito-Satoh, Takeharu Hayashi, Megumi Takahashi, Takuro Arimura, Michio Yasunami et al.
      Pages 195-206

  3. Nutrition, Metabolism and Cardiovascular Health

    1. Front Matter

      Pages 207-207
      Download chapter PDF

    2. Flavanol-Rich Foods and Cardiovascular Health

      • Carl L. Keen, Roberta R. Holt, Fernando Carrasquedo, M. Eric Gershwin, Tin K. Mao, Harold H. Schmitz
      Pages 209-226

    3. Benefits of Dietary Fiber for Cardiovascular Disease and Diabetes

      • Qiming Shao, Pamela M. Keagy
      Pages 227-241
Back to top

Keywords

About this book

The Frontiers in Cardiovascular Health varies between and within nations, depend­ ing upon the level at which the battle is fought for better cardiovascular health. According to the 1997 World Health Report, 15 million deaths (i. e. 30% of the total number of deaths) were attributable to cardiovascular diseases and this number is on the rise. The projection for the year 2020 is quite alarming with an expected cardiovascular mortality reaching 50 million. Much of this burden is projected to occur in developing countries, more specifically in the most populous countries of the world, namely China and India. These countries are already burdened with infectious and parasitic diseases and are trying to eradicate such diseases. With increasing life expectancies people all over the world, especially in developing coun­ tries, are exposed to degenerative atherosclerosis resulting in increased cardiovascu­ lar mortality and morbidity. In developing countries, resources available for health care are very limited. For example many of the African countries spend less than $10 per person per year on his/her entire health care let alone cardiovascular health. The average health care budget for nearly two thirds of the global population is well below $100 per year, on a per capita basis. Therefore, in developing countries health promotion and primary prevention are the frontiers by necessity. Improving awareness and health education is not only a matter of choice but is an absolute necessity.

Editors and Affiliations

  • Institute of Cardiovascular Sciences St. Boniface General Hospital Research Centre Faculty of Medicine, University of Manitoba, Winnipeg, Canada

    Naranjan S. Dhalla, H. Ivan Berkowitz, Pawan K. Singal

  • Institute of Circulatory & Respiratory Health, Canadian Institutes of Health Research, Vancouver, Canada

    Arun Chockalingam

Bibliographic Information

  • Book Title: Frontiers in Cardiovascular Health

  • Editors: Naranjan S. Dhalla, Arun Chockalingam, H. Ivan Berkowitz, Pawan K. Singal

  • Series Title: Progress in Experimental Cardiology

  • DOI: https://doi.org/10.1007/978-1-4615-0455-9

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2003

  • Hardcover ISBN: 978-1-4020-7451-6Published: 30 September 2003

  • Softcover ISBN: 978-1-4613-5085-9Published: 29 October 2012

  • eBook ISBN: 978-1-4615-0455-9Published: 06 December 2012

  • Series ISSN: 1389-1774

  • Edition Number: 1

  • Number of Pages: XVII, 595

  • Topics: Cardiology, Epidemiology

Publish with us

Policies and ethics

Back to top

Search

Navigation